RAD51-INHIBITOREN

Patent europeic · EP3681884 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3681884
Numer da la dumonda
EP18782257
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-09-2018
Publitgà
22-07-2020
Concedì
01-06-2022
La protecziun finescha il pli tard
10-09-2038
Proxima taxa annuala scadenta
30-09-2026
Classas IPC
C07D 417/04 (2006.01)
C07D 417/14 (2006.01)
C07D 277/42 (2006.01)
C07D 277/28 (2006.01)
C07D 417/12 (2006.01)
A61P 25/28 (2006.01)
A61P 35/00 (2006.01)
A61P 37/00 (2006.01)
A61K 31/427 (2006.01)
Prioritad
US 201762556763 P 11.09.2017
US 201862711959 P 30.07.2018
Dumonda PCT
PCT/US2018/050391 11.09.2018
Publicaziun PCT
WO2019/051465 14.03.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2025

    Midada

    Published in Swissreg on 01.10.2025

  2. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  3. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  4. 12-04-2023

    Midada

    Published in Swissreg on 12.04.2023

  5. 01-10-2022

    Midada

    Published in Swissreg on 01.10.2022

  6. 01-06-2022

    Concedì

    Published in Swissreg on 01.06.2022

Partidas

Possessur

Cyteir Therapeutics, Inc.

128 Spring Street, Building A, Suite 510, Lexington, MA 02421, US

Inventur

CASTRO, Alfredo C.

Woburn MA 01801, US

MCCOMAS, Casey Cameron

Phoenixville PA 19460, US

VACCA, Joseph

Telford PA 18969, US

MACLAY, Tyler

Cambridge MA 02138, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.